Life cycle assessment of sequential microbial-based anaerobic-aerobic reactor technology developed onsite for treating textile effluent.

Although biological treatment of textile effluent is a preferred option for industries avoiding toxic chemical sludge production and disposal, requirement of several extra pre-treatment units like neutralization, cooling systems or additives, results in higher operational cost. In the present study, a pilot scale sequential microbial-based anaerobic-aerobic reactor technology (SMAART) was developed and operated for the treatment of real textile effluent in the industrial premises in continuous mode for 180 d. The results showed an average ∼95% decolourization along with ∼92% reduction in the chemical oxygen demand establishing the resilience against fluctuations in the inlet parameters and climate conditions. Moreover, the pH of treated effluent was also reduced from alkaline range (∼11.05) to neutral range (∼7.76) along with turbidity reduction from ∼44.16 NTU to ∼0.14 NTU. A comparative life cycle assessment (LCA) of SMAART with the conventional activated sludge process (ASP) showed that ASP caused 41.5% more negative impacts on environment than SMAART. Besides, ASP had 46.15% more negative impact on human health, followed by 42.85% more negative impact on ecosystem quality as compared to SMAART. This was attributed to less electricity consumption, absence of pre-treatment units (cooling and neutralization) and less volume of sludge generation (∼50%) while using SMAART. Hence, integration of SMAART within the industrial effluent treatment plant is recommended to achieve a minimum waste discharge system in pursuit of sustainability.

Role of neurosteroids in experimental 3-nitropropionic acid induced neurotoxicity in rats.

Huntington's disease is an autosomal dominant, progressive, and fatal neurodegenerative disease characterized by motor and non-motor symptoms. Systemic administration of 3-nitropropionic acid, a complex II inhibitor of the electron transport chain induces selective striatal lesions in rodents. Neurosteroids are synthesized in central nervous system, able to modulate GABAA receptor function and has been reported to have neuroprotective action. The present study has been designed to investigate the role of neurosteroids such as progesterone and pregnenolone which are positive and negative modulators of GABA respectively against 3-nitropropionic acid induced experimental Huntington's disease. Systemic administration of 3-nitropropionic acid (10mg/kg i.p.) for 14 days significantly reduced body weight, locomotor activity, motor coordination, balance beam walk performance, antioxidant defense enzymes (reduced glutathione and catalase) and significantly increase oxidative stress markers (lipid peroxidation and nitrite level) in striatum and cortex. 3-Nitropropionic acid treatment also increases pro-inflammatory cytokines (TNF-α and IL-1ß) level in striatum. Progesterone (10, 20mg/kg/day i.p.) treatments for 14 days significantly reversed the behavioral, antioxidant defense enzymes, oxidative stress marker and pro-inflammatory cytokines as compared to the 3-Nitropropionic acid treated group. Pregnenolone (1 and 2mg/kg i.p.), a negative modulator of GABAA pretreatment significantly reversed the protective effect of progesterone on behavioral and biochemical parameters. The results of the present study suggest that the positive GABAergic modulation may be beneficial for the treatment of motor disorder.